SAM #75N98026Q00642

NIH Proteomics Study Services Using Olink Reveal Kits

This opportunity is for advanced proteomics study services at the NIH's Center for Research on Genomics and Global Health (CRGGH): - Government buyer: Department of Health and Human Services (HHS), National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), Center for Research on Genomics and Global Health (CRGGH) - OEM highlighted: Olink - Olink Reveal Kits are specifically required for the proteomics analysis - Products/services requested: - Analytical services for a proteomics study using Olink Reveal Kits - Supports integrated analyses of metabolic disorders (e.g., Type 2 diabetes, obesity, hypertension) - Leverages existing phenotypic and -omics data from over 6,000 individuals - Unique requirements: - Use of Olink technology is mandatory for the study - No specific part numbers or quantities provided - Focus on advanced proteomics to further complex disease research

Description

The Center for Research on Genomics and Global Health (CRGGH) explores how genetic and environmental factors contribute to the onset of complex diseases like Type 2 diabetes, obesity, and hypertension. Over the past two decades, CRGGH has gathered phenotypic data from more than 6,000 individuals both in the United States and internationally.

To better understand the underlying causes of metabolic disorders, CRGGH researchers utilize a variety of analytical methods. Over the years, they have systematically collected diverse types of -omics data, including genomics, transcriptomics, proteomics and microbiomes—from all or some participants, aiming to conduct integrated analyses that unravel underpinning mechanisms of these diseases.

View original listing